.
MergerLinks Header Logo

New Deal


Announced

Laboratorios Sanfer to acquire Vitalis from ACON Investments.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

injectable pharmaceuticals

Pharmaceuticals

Colombia

Acquisition

Majority

Private

Private Equity

Cross Border

Single Bidder

Pending

Friendly

Synopsis

Edit

Laboratorios Sanfer, a pharmaceutical company, agreed to acquire Vitalis, a manufacturer and wholesaler of injectable products used in hospitals, medical institutions and pharmacies, from ACON Investments, a private equity firm. Financial terms were not disclosed. "The team at Vitalis is enthusiastic to begin this new era of growth, consolidating its position as a key player in the Latin American pharmaceutical market. We are confident that Sanfer's experience, know-how and leadership will exponentially boost the company's growth and expansion plans," Alberto Hernandez, ACON Partner.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US